Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro

Clinical and Experimental Allergy

Volumn 29, Issue 9, 1999, Pages 1281-1286

  Munakata, Y ^a   Umezawa, Y ^b   Iwata, S ^a   Dong, R P ^a   Yoshida, S ^c   Ishii, T ^a   Morimoto, C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD26; CD28; CD3; Costimulation; Interferon gamma; Interleukin 2; Interleukin 4; Interleukin 5; T cell; Terfenadine

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; TERFENADINE;

ALLERGIC DISEASE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

CELLS, CULTURED; CYTOKINES; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TERFENADINE; TH2 CELLS;

EID: 0032854826     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00611.x     Document Type: Article

References (27)

1. Woodward JK, Munro NL. Terfenadine, the first non-sedating antihistamine. Arzneimittelforschung 1982; 32:1154-6.
2. FDA, announces plan to halt marketing of terfenadine. Am J Health Syst Pharm 1997; 54:342.
3. Holen E, Elsayed S, Nyfors A. The effect of HI receptor antagonists on peripheral blood mononuclear cells, adenoid cells and primary cell lines. APMIS 1995; 103:98-106.
4. Massey WA, Lichtenstein I.M. The effect of antihistamines beyond HI antagonism in allergic inflammation. J Allergy Clin Immunol 1990; 86:1019-24.
5. Crampette L, Mainprice B, Bloom M, Bousquet J, Campbell AM. Inhibition of mediator and cytokine release from dispersed nasal polyp cells by Lerfenadine. Allergy 1996; 51:346-9.
6. + T cells. Immunol Today 1991; 12:392-5.
7. Romagnani S. Lymphokine production by human T cell in disease states. Ann Rev Immunol 1994; 12:227-57.
8. Del Prete GF, De Carli M, D'Elios MM et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23:1445-9.
9. + T cells, increased Th-2 type cytokine mRNA expression, and cosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92:313-24.
10. Maggi E, Biswas P, Del Prete G et al. Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146:1169-74.
11. Robey E, Allison JP. T-cell activation: Integration of signals from the antigen receptor and costimulatory molecule. Immunol Today 1995; 16:306-9.
12. Green JM, Noel PJ, Sperling AI et al. Absence of B-7 dependent responses in CD28-deficient mice. Immunity 1994; 1:501-8.
13. Freeman GJ, Borriello F, Hodes RJ et al. Uncovering of functional alternative CTLA-4 counter-receptor in B-7 deficient mice. Science 1993; 262:907-9.
14. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell response to antigen. Annu Rev Immunol 1993; 11: 91-212.
15. Morimoto C, Torimoto Y, Levinson G et al. 1F7, a novel cell surface molecule involved in helper function of CD4 cells. J Immunol 1989; 143:3430-9.
16. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathway. J Immunol 1990; 144:4092-100.
17. Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 1993; 90:4586-90.
18. Hatter DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985; 312:1405-11.
19. Nakao H, Eguchi K, Kawakami A et al. Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis. J Rheumatol 1989; 16:904-10.
20. Gimmi CD, Freeman GJ, Gribben JG et al. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991; 88:6575-69.
21. + cells in the pathogenesis of allergic disease. Proc Soc Exp Biol Med 1997; 215:11-20.
22. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12:227-57.
23. Konno S, Asano K, Okamoto K, Adachi M. Inhibition of cytokine production from human peripheral blood leukocytes by anti-allergic agents in vitro. Eur J Pharmacol 1994; 264:265-8.
24. Lahti A. Terfenadine does not inhibit non-immunologic contact urticaria. Contact Dermatitis 1987; 16:220-3.
25. Novak TJ, Rothenberg EV. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 1990; 87:9353-7.
26. Van der Pouw-Kraan T, Van Kooten C, Rensik I, Aarden L. Interleukin (IL) -4 production by human T cells: differential regulation of IL-4 vs. IL-2 Production Eur J Immunol 1992; 22; 1237-41.
27. Borger P, Kauffman HF, Postma DS, Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 1996; 87:691-8.